Home
Sarepta Therapeutics SRPT paid Tarplin, Downs & Young $80K for lobbying in Q4 2022 · Budget, Health Issues and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q4 2022
- Client
- Sarepta Therapeutics
- Reported
- 23/01/20
$280K on lobbying in 2022
What else happened in Sarepta Therapeutics around then
Filed or reported within 30 days of the trade day · 22/12/01~23/01/30Sarepta Therapeutics's other lobbying reports
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$50K
$50K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$90K
$90K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$220K
$220K
Reported 07/20
for Q2
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$110K
$110K
Reported 04/20
for Q1
- Sarepta Therapeutics
LobbyingSarepta Therapeutics
LobbyingSarepta Therapeutics
SRPT
$270K
$270K
Reported 04/20
for Q1